Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer

Annals of Surgery

Volumn 228, Issue 2, 1998, Pages 201-208

  Seifert, Joachim K ^a   Morris, David L ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; COLORECTAL CANCER; CRYOTHERAPY; FEMALE; HEART INFARCTION; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR VOLUME;

EID: 0032471126     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199808000-00009     Document Type: Article

References (42)

1. Ballantyne GH, Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer (suppl) 1993;71:4252-4266.
2. Hughes KS and the Registry of Hepatic Metastases. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 1988; 103:278-288.
3. Scheele J, Stang R, Altendorf-Hoffmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19:59-71.
4. Seifert JK, Junginger T. Resektion von Lebermetastasen kolorektaler Tumoren. Eine uni- und multivariate Analyse von Prognosefaktoren. Langenhecks Arch Chir 1996; 381:187-200.
5. Nordlinger B, Guiguet M, Vaillant J-C, et al. Association Française de Chirurgie. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 1996; 77:1254-1262.
6. Ravikumar TS, Steele G Jr, Kane R, King V. Experimental and clinical observations on hepatic cryosurgery for colorectal metastases. Cancer Res 1991;51:6323-6327.
7. Morris DL, Ross WB, Iqbal J, et al. Cryoablation of hepatic malignancy: an evaluation of tumour marker data and survival in 110 patients. GI Cancer 1996; 1:247-251.
8. Adam R, Akpinar E, Johann M, et al. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 1997; 225:39-50.
9. Korpan NN. Hepatic cryosurgery for liver metastases. Long-term follow-up. Ann Surg 1997; 225:193-201.
10. Yeh KE, Fortunato L, Hoffman JP, Eisenberg BL. Cryosurgical ablation of hepatic metastases from colorectal carcinomas. Am Surg 1997; 63:63-68.
11. Seifert JK, Jungínger T, Morrís DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edinb (in press).
12. Ravikumar TS, Kane R, Cady B, et al. A 5-year study of cryosurgery in the treatment of liver tumors. Arch Surg 1991; 126:1520-1524.
13. Weaver ML, Atkinson D, Zemel R. Hepatic cryosurgery in treating colorectal metastases. Cancer 1995; 76:210-214.
14. Dwerryhouse SJ, Seifert JK, McCall JL, et al. Hepatic resection with cryotherapy to involved or inadequate resection margin (edge freeze) for metastases from colorectal cancer. Br J Surg 1998; 85(2): 185-187.
15. Ross WB, Horton M, Bertolino P, Morris DL. Cryotherapy of liver tumours: a practical guide. HPB Surgery 1995; 8:167-173.
16. Dilley AV, Dy DY, Warlters A, et al. Laboratory and animal model in evaluation of the Cryotech LCS 2000 in hepatic cryotherapy. Cryobiology 1993; 30:74-85.
17. Cozzi PJ, Stewart GJ, Morris DL. Thrombocytopenia after hepatic cryotherapy for colorectal metastases: correlates with hepatocellular injury. World J Surg 1994; 18:774-777.
18. Stewart, GJ, Preketes A, Horton M, et al. Hepatic cryotherapy: double-freeze cycles achieve greater hepatocellular injury in man. Cryobiology 1995; 32:215-219.
19. Seifert JK, Soon PS, Glen D, Morris DL. FUDR causes bilomas following hepatic cryotherapy. Aust N Z J Surg (abstract, in press).
20. Kaplan L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1985; 53:457-481.
21. Mantel N. Evaluation of survival data and and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50:163-170.
22. Cox DR. Regression models and life table. J Stat Soc 1972; 34:187-220.
23. Onik G, Rubinsky B, Zemel R, et al. Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Preliminary results. Cancer 1991; 67:901-907.
24. Shalir M, Shapiro R, Sung M, et al. Cryoablation of unresectable malignant liver tumors. Am J Surg 1996; 171:27-31.
25. Steele G, Ravikumar TS, Benotti PN. New surgical treatments for recurrent colorectal cancer. Cancer 1990; 65:723-730.
26. Preketes AP, King J, Caplehorn JRM, et al. CEA reduction after cryotherapy for liver metastases from colon cancer predicts survival. Aust NZ J Surg 1994; 64:612-614.
27. Weaver ML, Atkinson D, Zemel R. Hepatic cryosurgery in the treatment of unresectable metastases. Surg Oncol 1995; 4:231-236.
28. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992; 10:1112-1118.
29. Allen-Mersh TG, Earlam S, Fordy C, et al. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344:1255-1259.
30. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996; 88:252-257.
31. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15:938-946.
32. Hohenberger P, Schlag PM, Gerneth T, Herfarth C. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis. Ann Surg 1994; 219:135-143.
33. Cuschieri A, Crosthwaite G, Shimi S, et al. Hepatic cryotherapy for liver tumors. Surg Endosc 1995; 9:483-489.
34. McKinnon JG, Temple WJ, Wiseman DA, Saliken JC. Cryosurgery for malignant tumours of the liver. Can J Surg 1996; 39:401-406.
35. Sarantou T, Bilchik A, Ramming K. Cryoablation of primary and metastatic liver cancer unresponsive to conventional therapy. Proceedings of ASCO 1997; 16:304A.
36. Iwatsuki S, Esquivel CO, Gordon RD, Starzl TE. Liver resection for metastatic colorectal cancer. Surgery 1986; 100:804-810.
37. Stehlin JS, De Ipolyi PD, Greeff PJ, et al. Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients. Ann Surg 1988; 208:23-35.
38. Wanebo HJ, Chu QD, Vezeridis MP, Soderberg C. Patient selection for hepatic resection of colorectal metastases. Arch Surg 1996; 131: 322-329.
39. Awad N, Ross WB, Preketes A, Morris DL. Effect of peri-operative blood transfusion on survival after hepatic cryosurgery (for metastatic colorectal cancer). Surg Res Comm 1994; 16:59-63.
40. Cady B, Stone MD, McDermott WV, et al. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg 1992; 127:561-569.
41. Younes RN, Rogatko A, Brennan MF. The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg 1991; 214:107-113.
42. King J. Caplehorn JRM, Ross WB, Morris DL. High serum carcino-embryonic antigen concentration in patients with colorectal liver metastases is associated with poor cell-mediated immunity which is predictive of survival. Br J Surg 1998; 84(10): 1382-1385.